» Articles » PMID: 28356034

The Role of Redox Dysregulation in the Inflammatory Response to Acute Myocardial Ischaemia-reperfusion Injury - Adding Fuel to the Fire

Overview
Journal Curr Med Chem
Specialty Chemistry
Date 2017 Mar 31
PMID 28356034
Citations 28
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The inflammatory response to acute myocardial ischaemia/ reperfusion injury (IRI) plays a critical role in determining myocardial infarct (MI) size, and subsequent post-MI left ventricular (LV) remodelling, making it a potential therapeutic target for improving clinical outcomes in patients presenting with an acute myocardial infarction (AMI). Recent experimental studies using advanced imaging and molecular techniques, have yielded new insights into the mechanisms through which reactive oxygen species (ROS) contribute to the inflammatory response induced by acute myocardial IRI - "adding fuel to the fire". The infiltration of inflammatory cells into the MI zone, leads to elevated myocardial concentrations of ROS, cytokine release, and activation of apoptotic and necrotic death pathways. Anti-oxidant and anti-inflammatory therapies have failed to protect the heart against acute myocardial IRI. This may be, in part, due to a lack of understanding of the time course, nature and mechanisms of the inflammation and redox dysregulation, which occur in the setting of acute myocardial IRI.

Conclusion: In this article, we examine the inflammatory response and redox dysregulation induced by acute myocardial IRI, and highlight potential therapeutic options for targeting redox dysregulation, in order to attenuate the detrimental effects of the inflammatory response following an AMI, so as to reduce MI size and prevent heart failure.

Citing Articles

SUZ12-Increased NRF2 Alleviates Cardiac Ischemia/Reperfusion Injury by Regulating Apoptosis, Inflammation, and Ferroptosis.

Zhang G, Ma Z, Ma Z, Liu P, Zhang L, Lian Z Cardiovasc Toxicol. 2024; 25(1):97-109.

PMID: 39729180 DOI: 10.1007/s12012-024-09950-6.


Antioxidative and cardioprotective effects of minocycline in ischemia/reperfusion injury in experimental model of hypertension.

Rudic T, Stojanovic A, Sobot N, Novakovic J, Bolevich S, Bolevich S Mol Cell Biochem. 2024; 480(3):1747-1762.

PMID: 39187740 DOI: 10.1007/s11010-024-05095-w.


miR-124-3p downregulates EGR1 to suppress ischemia-hypoxia reperfusion injury in human iPS cell-derived cardiomyocytes.

Yang Q, Murata K, Ikeda T, Minatoya K, Masumoto H Sci Rep. 2024; 14(1):14811.

PMID: 38926457 PMC: 11208498. DOI: 10.1038/s41598-024-65373-x.


Exercise Improves Heart Function after Myocardial Infarction: The Merits of AMPK.

Zhang X, Zhao Y, Guo D, Luo M, Zhang Q, Zhang L Cardiovasc Drugs Ther. 2024; .

PMID: 38436878 DOI: 10.1007/s10557-024-07564-2.


Therapeutic Role of Chinese Medicine Targeting Nrf2/HO-1 Signaling Pathway in Myocardial Ischemia/Reperfusion Injury.

Liu C, Guo X, Zhou Y, Wang H Chin J Integr Med. 2024; 30(10):949-960.

PMID: 38329655 DOI: 10.1007/s11655-024-3657-0.